Brimonidine Toxicity Secondary to Topical Use for an Ulcerated Hemangioma
Brimonidine Toxicity Secondary to Topical Use for an Ulcerated Hemangioma is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Brimonidine Toxicity Secondary to Topical Use for an Ulcerated Hemangioma have?
Brimonidine Toxicity Secondary to Topical Use for an Ulcerated Hemangioma has 20 citations in the OpenAlex counts ScholarIQ stores.
When was Brimonidine Toxicity Secondary to Topical Use for an Ulcerated Hemangioma published?
Brimonidine Toxicity Secondary to Topical Use for an Ulcerated Hemangioma has 2016 year in the ScholarIQ index.
What is the open-access status of Brimonidine Toxicity Secondary to Topical Use for an Ulcerated Hemangioma?
Brimonidine Toxicity Secondary to Topical Use for an Ulcerated Hemangioma has closed oa status in the ScholarIQ index.
What is the DOI of Brimonidine Toxicity Secondary to Topical Use for an Ulcerated Hemangioma?
The DOI for Brimonidine Toxicity Secondary to Topical Use for an Ulcerated Hemangioma is on the source record.
What is the PMID of Brimonidine Toxicity Secondary to Topical Use for an Ulcerated Hemangioma?
The PMID for Brimonidine Toxicity Secondary to Topical Use for an Ulcerated Hemangioma is on the source record.
What is the OpenAlex record for Brimonidine Toxicity Secondary to Topical Use for an Ulcerated Hemangioma?
The OpenAlex for Brimonidine Toxicity Secondary to Topical Use for an Ulcerated Hemangioma is on the source record.